Sodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to improve
cardiovascular and renal outcomes in patients with established cardiovascular disease …

Ischemic heart disease (IHD) is a common clinical cardiovascular disease with high
morbidity and mortality. Sodium glucose cotransporter protein inhibitor (SGLTi) is a novel …

Objective. To investigate the effect of dapagliflozin therapy on the clinical outcome of drug‐
eluting stent (DES) implantation in elderly patients with type 2 diabetes mellitus (T2DM) …

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are antihyperglycemic drugs that
decrease mortality from cardiovascular diseases. However, their effects on hemostasis in the …

Introduction This prospective pharmacodynamic nutraceutical study assessed the effect of a
1-week trial of 30 g/day of 65% cocoa (dark chocolate)(Theobroma cacao L.) consumption …

Purpose The aim of this study is to evaluate the safety of this drug in diabetic patients with
comorbidities of all systems. Method In this review, the beneficial effects of this drug and its …

Introduction This prospective, single-arm, crossover pharmacodynamic study assessed the
effect of Bayer® low-dose enteric-coated aspirin 81 mg tablets (LD EC-ASA)(Bayer AG …

Objective. To investigate the efficacy of dapagliflozin for diabetes mellitus complicated by
coronary artery diseases and its impact on vascular endothelial function. Methods. Between …

Objective. To investigate the effect of dapagliflozin therapy on the clinical outcome of drug-
eluting stent (DES) implantation in elderly patients with type 2 diabetes mellitus (T2DM) …